 |
|
|
REFERENCES
1.
Zwolak RM, Cronenwett JL: Pathophysiology of vascular
disease. In Yeager MP, Glass DD (eds): Anesthesiology
and Vascular Surgery. East Norwalk, CT, Appleton & Lange, 1990, pp 3–29.
2.
Ross R, Harker L: Hyperlipidemia and atherosclerosis.
Science 193:1094–1100, 1976.
3.
Virchow R: Phlogose und thrombose im gefassystem.
In Anesthesiology and Vascular Surgery. Frankfurt-am-Main,
Meidinger Sohn, 1856, p 458.
4.
Ross R, Glomset JA: The pathogenesis of atherosclerosis
[first of two parts]. N Engl J Med 295:369–377, 1976.
5.
Ross R, Glomset JA: The pathogenesis of atherosclerosis
[second of two parts]. N Engl J Med 295:420–425, 1976.
6.
Ross R: Atherosclerosis: An inflammatory disease.
N Engl J Med 340:115–126, 1999.
7.
Benditt EP, Benditt JM: Evidence for a monoclonal
origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A 70:1753–1756,
1973.
8.
Martin GM, Sprague CA: Symposium on in vitro studies
related to atherogenesis: Life histories of hyperplastoid cell lines from aorta
and skin. Exp Mol Pathol 18:125–141, 1973.
9.
Libby P, Ridker PM, Maseri A: Inflammation and
atherosclerosis. Circulation 105:1135–1143, 2002.
10.
Aikawa M, Rabkin E, Sugiyama S, et al: An HMG-CoA
reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix
metalloproteinases and tissue factor in vivo and in vitro. Circulation 103:276–283,
2001.
11.
Ridker PM: High-sensitivity C-reactive protein:
Potential adjunct for global risk assessment in the primary prevention of cardiovascular
disease. Circulation 103:1813–1818, 2001.
12.
Horowitz GL, Beckwith BA: C-reactive protein in
the prediction of cardiovascular disease. N Engl J Med 343:512–513, 2000.
13.
Liuzzo G, Biasucci LM, Gallimore JR, et al: The
prognostic value of C-reactive protein and serum amyloid a protein in severe unstable
angina. N Engl J Med 331:417–424, 1994.
14.
Ridker PM, Cushman M, Stampfer MJ, et al: Plasma
concentration of C-reactive protein and risk of developing peripheral vascular disease.
Circulation 97:425–428, 1998.
15.
Murray WM: Inflammation, aspirin, and the risk
of cardiovascular disease. N Engl J Med 337:422, author reply 423–424, 1997.
16.
Fry DL: Acute vascular endothelial changes associated
with increased blood velocity gradients. Circ Res 22:165–197, 1968.
17.
LaRosa JC, Hunninghake D, Bush D, et al: The cholesterol
facts: A summary of the evidence relating dietary fats, serum cholesterol, and coronary
heart disease. A joint statement by the American Heart Association and the National
Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American
Heart Association. Circulation 81:1721–1733, 1990.
18.
Shepherd J, Cobbe SM, Ford I, et al: Prevention
of coronary heart disease with pravastatin in men with hypercholesterolemia. West
of Scotland Coronary Prevention Study Group. N Engl J Med 333:1301–1307, 1995.
19.
Prevention of cardiovascular events and death with
pravastatin in patients with coronary heart disease and a broad range of initial
cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease
(LIPID) Study Group. N Engl J Med 339:1349–1357, 1998.
20.
MRC/BHF Heart Protection Study of cholesterol lowering
with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled
trial. Lancet 360:7–22, 2002.
21.
Small DM: George Lyman Duff memorial lecture.
Progression and regression of atherosclerotic lesions: Insights from lipid physical
biochemistry. Arteriosclerosis 8:103–129, 1988.
22.
Burkman RT: Lipid and lipoprotein changes in relation
to oral contraception and hormonal replacement therapy. Fertil Steril 49(Suppl 2):39S–50S,
1988.
23.
Salonen RM, Nyyssonen K, Kaikkonen J, et al: Six-year
effect of combined vitamin C and E supplementation on atherosclerotic progression:
The Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation
107:947–953, 2003.
24.
Roizen MF: Arterial aging: Keeping the roadways
clear. In Real Age: Are You as Young as You Can
Be? New York, Harper Collins, 1999.
25.
Roizen MF: www.realage.com.
26.
Mangano DT: Perioperative cardiac morbidity.
Anesthesiology 72:153–184, 1990.
27.
Hertzer NR: Cardiac risk factors in peripheral
vascular surgery. In Estafanous FG (ed): Anesthesia
and the Heart Patient. Oxford, Butterworth-Heinemann, 1989, pp 173–195.
28.
Bry JD, Belkin M, O'Donnell TF Jr, et al: An assessment
of the positive predictive value and cost-effectiveness of dipyridamole myocardial
scintigraphy in patients undergoing vascular surgery. J Vasc Surg 19:112–121,
discussion 121–124, 1994.
29.
Krupski WC, Nehler MR, Whitehill TA: Preoperative
cardiac risk management. Cardiovasc Surg 10:415–420, 2002.
30.
McFalls EO, Ward HB, Krupski WC, et al: Prophylactic
coronary artery revascularization for elective vascular surgery: Study design.
Veterans Affairs Cooperative Study Group on Coronary Artery Revascularization Prophylaxis
for Elective Vascular Surgery. Control Clin Trials 20:297–308, 1999.
31.
Eagle KA, Brundage BH, Chaitman BR, et al: Guidelines
for perioperative cardiovascular evaluation for noncardiac surgery. Report of the
American College of Cardiology/American Heart Association Task Force on Practice
Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery).
J Am Coll Cardiol 27:910–948, 1996.
32.
Eagle KA, Berger PB, Calkins H, et al: ACC/AHA
guideline update for perioperative cardiovascular evaluation for noncardiac surgery—Executive
summary: A report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative
Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 39:542–553,
2002.
33.
Krupski WC: Update on perioperative evaluation
and management of cardiac disease in vascular surgery patients. J Vasc Surg 36:1292–1308,
2002.
34.
Goldman L, Caldera DL, Nussbaum SR, et al: Multifactorial
index of cardiac risk in noncardiac surgical procedures. N Engl J Med 297:845–850,
1977.
35.
Lette J, Waters D, Lassonde J, et al: Multivariate
clinical models and quantitative dipyridamole-thallium imaging to predict cardiac
morbidity and death after vascular reconstruction. J Vasc Surg 14:160–169,
1991.
36.
Lette J, Waters D, Bernier H, et al: Preoperative
and long-term cardiac risk assessment: Predictive value of 23 clinical descriptors,
7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients.
Ann Surg 216:192–204, 1992.
37.
Detsky AS, Abrams HB, Forbath N, et al: Cardiac
assessment for patients undergoing noncardiac surgery: A multifactorial clinical
risk index. Arch Intern Med 146:2131–2134, 1986.
38.
Detsky AS, Abrams HB, McLaughlin JR, et al: Predicting
cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med
1:211–219, 1986.
39.
Zeldin RA: Assessing cardiac risk in patients
who undergo noncardiac surgical procedures. Can J Surg 27:402–404, 1984.
40.
Lee TH, Marcantonio ER, Mangione CM, et al: Derivation
and prospective validation of a simple index for prediction of cardiac risk of major
noncardiac surgery. Circulation 100:1043–1049, 1999.
41.
Chiariello M, Indolfi C: Silent myocardial ischemia
in patients with diabetes mellitus. Circulation 93:2089–2091, 1996.
42.
Goldman L, Caldera DL, Southwick FS, et al: Cardiac
risk factors and complications in non-cardiac surgery. Medicine (Baltimore) 57:357–370,
1978.
43.
Steen PA, Tinker JH, Tarhan S: Myocardial reinfarction
after anesthesia and surgery. JAMA 239:2566–2570, 1978.
44.
Tarhan S, Moffitt EA, Taylor WF, Giuliani ER:
Myocardial infarction after general anesthesia. JAMA 220:1451–1454, 1972.
45.
L'Italien GJ, Paul SD, Hendel RC, et al: Development
and validation of a Bayesian model for perioperative cardiac risk assessment in a
cohort of 1,081 vascular surgical candidates. J Am Coll Cardiol 27:779–786,
1996.
46.
Fleisher LA, Barash PG: Preoperative cardiac evaluation
for noncardiac surgery: A functional approach. Anesth Analg 74:586–598, 1992.
47.
Reilly DF, McNeely MJ, Derner D, et al: Self-reported
exercise tolerance and the risk of serious perioperative complications. Arch Intern
Med 159:2185–2192, 1999.
48.
Bartels C, Bechtel JF, Hossmann V, Horsch S: Cardiac
risk stratification for high-risk vascular surgery. Circulation 95:2473–2475,
1997.
49.
Hertzer NR, Beven EG, Young JR, et al: Coronary
artery disease in peripheral vascular patients: A classification of 1000 coronary
angiograms and results of surgical management. Ann Surg 199:223–233, 1984.
50.
Krupski WC, Layug EL, Reilly LM, et al: Comparison
of cardiac morbidity between aortic and infrainguinal operations. Study of Perioperative
Ischemia (SPI) Research Group. J Vasc Surg 15:354–363, discussion 364–365,
1992.
51.
Krupski WC, Layug EL, Reilly LM, et al: Comparison
of cardiac morbidity rates between aortic and infrainguinal operations: Two-year
follow-up. Study of Perioperative Ischemia Research Group. J Vasc Surg 18:609–615,
discussion 615–617, 1993.
52.
Fleisher LA, Nelson AH, Rosenbaum SH: Failure
of negative dipyridamole thallium scans to predict perioperative myocardial ischaemia
and infarction. Can J Anaesth 39:179–183, 1992.
53.
Ashton CM, Petersen NJ, Wray NP, et al: The incidence
of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann
Intern Med 118:504–510, 1993.
54.
Raby KE, Barry J, Creager MA, et al: Detection
and significance of intraoperative and postoperative myocardial ischemia in peripheral
vascular surgery. JAMA 268:222–227, 1992.
55.
Slogoff S, Keats AS: Does perioperative myocardial
ischemia lead to postoperative myocardial infarction? Anesthesiology 62:107–114,
1985.
56.
The fifth report of the Joint National Committee
on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern
Med 153:154–183, 1993.
57.
Slogoff S, Keats AS: Does chronic treatment with
calcium entry blocking drugs reduce perioperative myocardial ischemia? Anesthesiology
68:676–680, 1988.
58.
Stone JG, Foex P, Sear JW, et al: Myocardial ischemia
in untreated hypertensive patients: Effect of a single small oral dose of a beta-adrenergic
blocking agent. Anesthesiology 68:495–500, 1988.
59.
Pasternack PF, Grossi EA, Baumann FG, et al: Beta
blockade to decrease silent myocardial ischemia during peripheral vascular surgery.
Am J Surg 158:113–116, 1989.
60.
Mangano DT, Layug EL, Wallace A, Tateo I: Effect
of atenolol on mortality and cardiovascular morbidity after noncardiac surgery.
Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713–1720,
1996.
61.
Wallace A, Layug B, Tateo I, et al: Prophylactic
atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology
88:7–17, 1998.
62.
Poldermans D, Boersma E, Bax JJ, et al: The effect
of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients
undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying
Stress Echocardiography Study Group. N Engl J Med 341:1789–1794, 1999.
63.
Poldermans D, Boersma E, Bax JJ, et al: Bisoprolol
reduces cardiac death and myocardial infarction in high-risk patients as long as
2 years after successful major vascular surgery. Eur Heart J 22:1353–1358,
2001.
64.
Flacke JW, Bloor BC, Flacke WE, et al: Reduced
narcotic requirement by clonidine with improved hemodynamic and adrenergic stability
in patients undergoing coronary bypass surgery. Anesthesiology 67:11–19, 1987.
65.
Ghignone M, Calvillo O, Quintin L: Anesthesia
and hypertension: The effect of clonidine on perioperative hemodynamics and isoflurane
requirements. Anesthesiology 67:3–10, 1987.
66.
Coriat P, Richer C, Douraki T, et al: Influence
of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology
81:299–307, 1994.
67.
Rao TL, Jacobs KH, El-Etr AA: Reinfarction following
anesthesia in patients with myocardial infarction. Anesthesiology 59:499–505,
1983.
68.
Ryan TJ, Antman EM, Brooks NH, et al: 1999 Update:
ACC/AHA guidelines for the management of patients with acute myocardial infarction—Executive
summary and recommendations: A report of the American College of Cardiology/American
Heart Association Task Force on Practice Guidelines (Committee on Management of Acute
Myocardial Infarction). Circulation 100:1016–1030, 1999.
69.
Fisch C: Evolution of the clinical electrocardiogram.
J Am Coll Cardiol 14:1127–1138, 1989.
70.
Guidelines for assessing and managing the perioperative
risk from coronary artery disease associated with major noncardiac surgery. American
College of Physicians. Ann Intern Med 127:309–312, 1997.
71.
Cutler BS, Wheeler HB, Paraskos JA, Cardullo PA:
Applicability and interpretation of electrocardiographic stress testing in patients
with peripheral vascular disease. Am J Surg 141:501–506, 1981.
72.
McPhail N, Calvin JE, Shariatmadar A, et al: The
use of preoperative exercise testing to predict cardiac complications after arterial
reconstruction. J Vasc Surg 7:60–68, 1988.
73.
Takase B, Younis LT, Byers SL, et al: Comparative
prognostic value of clinical risk indexes, resting two-dimensional echocardiography,
and dipyridamole stress thallium-201 myocardial imaging for perioperative cardiac
events in major nonvascular surgery patients. Am Heart J 126:1099–1106, 1993.
74.
Kaaja R, Sell H, Erkola O, Harjula A: Predictive
value of manual ECG-monitored exercise test before abdominal aortic or peripheral
vascular surgery. Angiology 44:11–15, 1993.
75.
Baron JF, Mundler O, Bertand M, et al: Dipyridamolethallium
scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal
aortic surgery. N Engl J Med 330:663–669, 1994.
76.
Mangano DT, London MJ, Tubau JF, et al: Dipyridamole
thallium-201 scintigraphy as a preoperative screening test: A reexamination of its
predictive potential. Study of Perioperative Ischemia Research Group. Circulation
84:493–502, 1991.
77.
Eagle K, Coley CM, Newell JB, et al: Combining
clinical and thallium data optimizes preoperative assessment of cardiac risk before
major vascular surgery. Ann Intern Med 110:859–866, 1989.
78.
Fleisher LA, Rosenbaum SH, Nelson AH, et al: Preoperative
dipyridamole thallium imaging and ambulatory electrocardiographic monitoring as a
predictor of perioperative cardiac events and long-term outcome. Anesthesiology
83:906–917, 1995.
79.
Christopherson R, Beattie C, Fran SM, et al: Perioperative
morbidity in patients randomized to epidural or general anesthesia for lower extremity
vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group.
Anesthesiology 79:422–434, 1993.
80.
Raby KE, Goldman L, Creager MA, et al: Correlation
between preoperative ischemia and major cardiac events after peripheral vascular
surgery. N Engl J Med 321:1296–1300, 1989.
81.
Gottlieb SO: Perioperative myocardial ischemia
and infarction: Detection of myocardial ischemia using continuous electrocardiography.
Int Anesthesiol Clin 30:19–30, 1992.
82.
Gottlieb SO, Gottlieb SH, Achuff SC, et al: Silent
ischemia on Holter monitoring predicts mortality in high-risk postinfarction patients.
JAMA 259:1030–1035, 1988.
83.
Gottlieb SO, Weisfeldt ML, Ouyang P, et al: Silent
ischemia as a marker for early unfavorable outcomes in patients with unstable angina.
N Engl J Med 314:1214–1219, 1986.
84.
Ouyang P, Gerstenblith G, Furman WR, et al: Frequency
and significance of early postoperative silent myocardial ischemia in patients having
peripheral vascular surgery. Am J Cardiol 64:1113–1136, 1989.
85.
Frank SM, Beattie C, Christopherson R, et al:
Perioperative rate-related silent myocardial ischemia and postoperative death. J
Clin Anesth 2:326–331, 1990.
86.
Pasternack PF, Grossi EA, Baumann FG, et al: The
value of silent myocardial ischemia monitoring in the prediction of perioperative
myocardial infarction in patients undergoing peripheral vascular surgery. J Vasc
Surg 10:617–625, 1989.
87.
Mangano DT, Browner WS, Hollenberg M, et al: Association
of perioperative myocardial ischemia with cardiac morbidity and mortality in men
undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group.
N Engl J Med 323:1781–1788, 1990.
88.
Goldman L: Cardiac risk assessment in patients
with arteriosclerotic vascular disease. In Kaplan
JA (ed): Vascular Anesthesia. New York, Churchill Livingstone, 1991, pp 1–20.
89.
Robotham JL, Takata M, Berman M, Harasawa Y: Ejection
fraction revisited. Anesthesiology 74:172–183, 1991.
90.
Nishimura RA, Reeder GS, Miller FA Jr, et al:
Prognostic value of predischarge 2-dimensional echocardiogram after acute myocardial
infarction. Am J Cardiol 53:429–432, 1984.
91.
Boersma E, Poldermans D, Bax JJ, et al: Predictors
of cardiac events after major vascular surgery: Role of clinical characteristics,
dobutamine echocardiography, and beta-blocker therapy. JAMA 285:1865–1873,
2001.
92.
Chaudhry FA, Tauke JT, Alessandrini RS, et al:
Enhanced detection of ischemic myocardium by transesophageal dobutamine stress echocardiography:
Comparison with simultaneous transthoracic echocardiography. Echocardiography 17:241–253,
2000.
93.
Lalka SG, Sawada SG, Dalsing MC, et al: Dobutamine
stress echocardiography as a predictor of cardiac events associated with aortic surgery.
J Vasc Surg 15:831–840, discussion 841–842, 1992.
94.
Langan EM 3rd, Youkey JR, Franklin DP, et al:
Dobutamine stress echocardiography for cardiac risk assessment before aortic surgery.
J Vasc Surg 18:905–911, discussion 912–913, 1993.
95.
Poldermans D, Fioretti PM, Forster T, et al: Dobutamine
stress echocardiography for assessment of perioperative cardiac risk in patients
undergoing major vascular surgery. Circulation 87:1506–1512, 1993.
96.
Davila-Roman VG, Waggoner AD, Sicard GA, et al:
Dobutamine stress echocardiography predicts surgical outcome in patients with an
aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 21:957–963,
1993.
97.
Eichelberger JP, Scharz KQ, Black ER, et al: Predictive
value of dobutamine echocardiography just before noncardiac vascular surgery. Am
J Cardiol 72:602–607, 1993.
98.
Poldermans D, Arnese M, Fioretti PM, et al: Improved
cardiac risk stratification in major vascular surgery with dobutamine-atropine stress
echocardiography. J Am Coll Cardiol 26:648–653, 1995.
99.
Mantha S, Roizen MF, Barnard J, et al: Relative
effectiveness of four preoperative tests for predicting adverse cardiac outcomes
after vascular surgery: A meta-analysis. Anesth Analg 79:422–433, 1994.
100.
Pasternack PF, Imparato AM, Bear G, et al: The
value of radionuclide angiography as a predictor of perioperative myocardial infarction
in patients undergoing abdominal aortic aneurysm resection. J Vasc Surg 1:320–325,
1984.
101.
Pasternack PF, Imparato AM, Riles TS, et al:
The value of the radionuclide angiogram in the prediction of perioperative myocardial
infarction in patients undergoing lower extremity revascularization procedures.
Circulation 72(Pt 2):II13–II17, 1985.
102.
Franco CD, Goldsmith J, Veith FJ, et al: Resting
gated pool ejection fraction: A poor predictor of perioperative myocardial infarction
in patients undergoing vascular surgery for infrainguinal bypass grafting. J Vasc
Surg 10:656–661, 1989.
103.
McCann RL, Wolfe WG: Resection of abdominal aortic
aneurysm in patients with low ejection fractions. J Vasc Surg 10:240–244,
1989.
104.
Karkos CD, Baguneid MS, Triposkiadis F, et al:
Routine measurement of radioisotope left ventricular ejection fraction prior to
vascular surgery: Is it worthwhile? Eur J Vasc Endovasc Surg 27:227–228,
2004.
105.
Hertzer NR, Young JR, Beven EG, et al: Late results
of coronary bypass in patients with peripheral vascular disease: II. Five-year
survival according to sex, hypertension, and diabetes. Cleve Clin J Med 54:15–23,
1987.
106.
Scanlon PJ, Faxon DP, Audet AM, et al: ACC/AHA
guidelines for coronary angiography. A report of the American College of Cardiology/American
Heart Association Task Force on practice guidelines (Committee on Coronary Angiography).
Developed in collaboration with the Society for Cardiac Angiography and Interventions.
J Am Coll Cardiol 33:1756–1824, 1999.
107.
Foster ED, Davis KB, Carpenter JA, et al: Risk
of noncardiac operation in patients with defined coronary disease: The Coronary
Artery Surgery Study (CASS) registry experience. Ann Thorac Surg 41:42–50,
1986.
108.
Hassan SA, Hlatky MA, Boothroyd DB, et al: Outcomes
of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the
Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 110:260–266,
2001.
109.
Back MR, Stordahl N, Cuthbertson D, et al: Limitations
in the cardiac risk reduction provided by coronary revascularization prior to elective
vascular surgery. J Vasc Surg 36:526–533, 2002.
110.
Nikolsky E, Mehran R, Mintz GS, et al: Impact
of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing
percutaneous coronary interventions. J Endovasc Ther 11:60–70, 2004.
111.
Allen JR, Helling TS, Hartzler GO: Operative
procedures not involving the heart after percutaneous transluminal coronary angioplasty.
Surg Gynecol Obstet 173:285–288, 1991.
112.
Huber KC, Evans MA, Bresnahan JF, et al: Outcome
of noncardiac operations in patients with severe coronary artery disease successfully
treated preoperatively with coronary angioplasty. Mayo Clin Proc 67:15–21,
1992.
113.
Stone GW, Ellis SG, Cox DA, et al: A polymer-based,
paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med
350:221–231, 2004.
114.
Wilson SH, Fasseas P, Orford JL, et al: Clinical
outcome of patients undergoing non-cardiac surgery in the two months following coronary
stenting. J Am Coll Cardiol 42:234–240, 2003.
115.
Kaluza GL, Joseph J, Lee JR, et al: Catastrophic
outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 35:1288–1294,
2000.
116.
Tisi GM: Preoperative evaluation of pulmonary
function: Validity, indications, and benefits. Am Rev Respir Dis 119:293–310,
1979.
117.
Hirshman CA: Perioperative management of the
asthmatic patient. Can J Anaesth 38(Pt 2):R26–R38, 1991.
118.
Yeager MP, Glass DD, Neff RK, Brinck-Johnsen T:
Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology
66:729–736, 1987.
119.
Byrd L, Sherman RL: Radiocontrast-induced acute
renal failure: A clinical and pathophysiologic review. Medicine (Baltimore) 58:270–279,
1979.
120.
Gamulin Z, Forster A, Simonet F, et al: Effects
of renal sympathetic blockade on renal hemodynamics in patients undergoing major
aortic abdominal surgery. Anesthesiology 65:688–692, 1986.
121.
Cronenwett JL, Lindenauer SM: Distribution of
intrarenal blood flow following aortic clamping and declamping. J Surg Res 22:469–482,
1977.
122.
Diehl JT, Cali RF, Hertzer NR, Beven EG: Complications
of abdominal aortic reconstruction: An analysis of perioperative risk factors in
557 patients. Ann Surg 197:49–56, 1983.
123.
Beattie C, Fleisher LA: Perioperative myocardial
ischemia and infarction. In Beattie C, Fleisher
LA (eds): International Anesthesiology Clinics. Boston, Little, Brown, 1992, pp
12–24.
124.
Nyhan D, Schultheis L: The role of oxygen-carrying
capacity in myocardial ischemia. In Beattie C, Fleisher
LA (eds): Perioperative Myocardial Ischemia and Infarction. Boston, Little, Brown,
1992, pp 101–113.
125.
Mangano DT, Hollenberg M, Fegert G, et al: Perioperative
myocardial ischemia in patients undergoing noncardiac surgery—I: Incidence
and severity during the 4 day perioperative period. The Study of Perioperative Ischemia
(SPI) Research Group. J Am Coll Cardiol 17:843–850, 1991.
126.
Mangano DT, Wong MG, London MJ, et al: Perioperative
myocardial ischemia in patients undergoing noncardiac surgery—II: Incidence
and severity during the 1st week after surgery. The Study of Perioperative Ischemia
(SPI) Research Group. J Am Coll Cardiol 17:851–857, 1991.
127.
Landesberg G, Mosseri M, Zahger D, et al: Myocardial
infarction after vascular surgery: The role of prolonged stress-induced, ST depression-type
ischemia. J Am Coll Cardiol 37:1839–1845, 2001.
128.
Breslow MJ, Parker SD, Frank SM, et al: Determinants
of catecholamine and cortisol responses to lower extremity revascularization. The
PIRAT Study Group. Anesthesiology 79:1202–1209, 1993.
129.
Mangano DT: Characteristics of electrocardiographic
ischemia in high-risk patients undergoing surgery. Study of Perioperative Ischemia
(SPI) Research Group. J Electrocardiol 23(Suppl):20–27, 1990.
130.
Fleisher LA, Rosenbaum SH, Neson AH, Barash PG:
The predictive value of preoperative silent ischemia for postoperative ischemic
cardiac events in vascular and nonvascular surgery patients. Am Heart J 122(Pt 1):980–986,
1991.
131.
Knight AA, Holleberg M, London MJ, et al: Perioperative
myocardial ischemia: Importance of the preoperative ischemic pattern. Anesthesiology
68:681–688, 1988.
132.
Norris EJ, Beattie C, Perler BA, et al: Double-masked
randomized trial comparing alternate combinations of intraoperative anesthesia and
postoperative analgesia in abdominal aortic surgery. Anesthesiology 95:1054–1067,
2001.
133.
Roy WL, Edelist G, Gilbert B: Myocardial ischemia
during non-cardiac surgical procedures in patients with coronaryartery disease.
Anesthesiology 51:393–397, 1979.
134.
Robinson BF: Relation of heart rate and systolic
blood pressure to the onset of pain in angina pectoris. Circulation 35:1073–1083,
1967.
135.
Moffitt EA, Sethna DH, Gray RJ, et al: Rate-pressure
product correlates poorly with myocardial oxygen consumption during anaesthesia in
coronary patients. Can Anaesth Soc J 31:5–12, 1984.
136.
Lieberman RW, Orkin FK, Jobes DR, Schwartz AJ:
Hemodynamic predictors of myocardial ischemia during halothane anesthesia for coronary-artery
revascularization. Anesthesiology 59:36–41, 1983.
137.
Buffington CW: Hemodynamic determinants of ischemic
myocardial dysfunction in the presence of coronary stenosis in dogs. Anesthesiology
63:651–662, 1985.
138.
Gordon MA, Urban MK, O'Connor T, Barash PG: Is
the pressure rate quotient a predictor or indicator of myocardial ischemia as measured
by ST-segment changes in patients undergoing coronary artery bypass surgery? Anesthesiology
74:848–853, 1991.
139.
Leung JM, O'Kelly BF, Mangano DT: Relationship
of regional wall motion abnormalities to hemodynamic indices of myocardial oxygen
supply and demand in patients undergoing CABG surgery. Anesthesiology 73:802–814,
1990.
140.
Consensus conference. Perioperative red blood
cell transfusion. JAMA 260:2700–2703, 1988.
141.
Practice strategies for elective red blood cell
transfusion. American College of Physicians. Ann Intern Med 116:403–406,
1992.
142.
Christopherson R, et al: Low postoperative hematocrit
is associated with cardiac ischemia in high risk patients [abstract]. Anesthesiology
75:A99, 1991.
143.
Nelson AH, Fleisher LA, Rosenbaum SH: Relationship
between postoperative anemia and cardiac morbidity in high-risk vascular patients
in the intensive care unit. Crit Care Med 21:860–866, 1993.
144.
Landesberg G, Luria MH, Cotev S, et al: Importance
of long-duration postoperative ST-segment depression in cardiac morbidity after vascular
surgery. Lancet 341:715–719, 1993.
145.
London MJ: Monitoring for myocardial ischemia.
In Kaplan JA (ed): Vascular Anesthesia. New York,
Churchill Livingstone, 1991, pp 249–287.
146.
Deanfield JE, Shea M, Ribiero P, et al: Transient
ST-segment depression as a marker of myocardial ischemia during daily life. Am J
Cardiol 54:1195–1200, 1984.
147.
Cohn PF, Brown EJ Jr, Wynne J, et al: Global
and regional left ventricular ejection fraction abnormalities during exercise in
patients with silent myocardial ischemia. J Am Coll Cardiol 1:931–933, 1983.
148.
Levy RD, Shapiro LM, Wright C, et al: The haemodynamic
significance of asymptomatic ST segment depression assessed by ambulatory pulmonary
artery pressure monitoring. Br Heart J 56:526–530, 1986.
149.
Gottlieb SO: Detection of myocardial ischemia
using continuous electrocardiography. In Beattie
C, Fleisher LA (eds): Perioperative Myocardial Ischemia and Infarction. Boston,
Little, Brown, 1992, pp 19–30.
150.
Arbeit SR, Rubin IL, Gross H: Dangers in interpreting
the electrocardiogram from the oscilloscope monitor. JAMA 211:453–456, 1970.
